Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH) Among 4,353 patients, we ...
Adherence is difficult to measure accurately. Studies of refill data, extended electronic bottle cap monitoring and drug levels are the most robust methodologies. There is a growing role for measuring ...
This review aims to provide a broad overview of the issues and clinical challenges of nonadherence in adolescents and young adults (AYAs) with cancer. Nonadherence can reduce treatment efficacy, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results